Cargando…
Ubenimex Reverses MDR in Gastric Cancer Cells by Activating Caspase-3-Mediated Apoptosis and Suppressing the Expression of Membrane Transport Proteins
Gastric cancer (GC) is one of the most malignant tumors, accounting for 10% of deaths caused by all cancers. Chemotherapy is often necessary for treatment of GC; the FOLFOX regimen is extensively applied. However, multidrug resistance (MDR) of GC cells prevents wider application of this treatment. U...
Autores principales: | Guo, Qie, Jing, Fan-jing, Qu, Hai-jun, Xu, Wen, Han, Bing, Xing, Xiao-min, Ji, Hong-yan, Jing, Fan-Bo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6402206/ https://www.ncbi.nlm.nih.gov/pubmed/30915355 http://dx.doi.org/10.1155/2019/4390839 |
Ejemplares similares
-
Ubenimex suppresses Pim-3 kinase expression by targeting CD13 to reverse MDR in HCC cells
por: Guo, Qie, et al.
Publicado: (2017) -
Ubenimex Suppresses the Ability of Migration and Invasion in Gastric Cancer Cells by Alleviating the Activity of the CD13/NAB1/MAPK Pathway
por: Liu, Xuehui, et al.
Publicado: (2021) -
Ubenimex suppresses glycolysis mediated by CD13/Hedgehog signaling to enhance the effect of cisplatin in liver cancer
por: Shi, Yunyan, et al.
Publicado: (2023) -
Ubenimex induces autophagy inhibition and EMT suppression to overcome cisplatin resistance in GC cells by perturbing the CD13/EMP3/PI3K/AKT/NF-κB axis
por: Guo, Qie, et al.
Publicado: (2019) -
CD13 downregulation mediated by ubenimex inhibits autophagy to overcome 5-FU resistance by disturbing the EMP3/FAK/NF-κB pathway in gastric cancer cells
por: Xiu, Ting, et al.
Publicado: (2022)